Juli Johnson, APRN
Oncology · Oklahoma City, OKNPI 1245404946
Payments from drug & device makers
Across 16 payments — averaging $21.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$106
- Ipsen Biopharmaceuticals, Inc$32
- Sanofi$31
- Johnson & Johnson$28
- Sumitomo Pharma America, Inc.$24
- Merck$21
- plus $95 from 5 others
What the payments were for
- Food & beverage$19758%
- Education$14042%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 5 | $106 |
| Ipsen Biopharmaceuticals, Inc | 2 | $32 |
| Sanofi | 1 | $31 |
| Johnson & Johnson | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Merck | 1 | $21 |
| Stemline Therapeutics Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| AstraZeneca | 1 | $20 |
| AbbVie | 1 | $17 |
| Bayer | 1 | $17 |
How this compares
Too few oncology providers in Oklahomato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Potassium Chloride | 58 | $751 |
| Omeprazole | 27 | $422 |
| Ondansetron Hcl | 33 | $372 |
| Levothyroxine Sodium | 45 | $372 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 18 | $365 |
| Anastrozole | 16 | $237 |
| Triamcinolone Acetonide | 14 | $237 |
| Gabapentin | 23 | $123 |
| Promethazine Hcl | 14 | $108 |
| Prednisone | 30 | $106 |
| Tramadol Hcl | 17 | $96 |
| Escitalopram Oxalate | 11 | $90 |
| Benazepril Hcl | 13 | $28 |
Paid to pharmacies, not to this prescriber.
Other oncology in Oklahoma City
- Melissa CraftOklahoma City$3K
- Ingrid BlockOklahoma City$30
- Debora HousewrightTulsa$340
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.